Joint Fondazione Aldo Torsoli – Rome Foundation Research Award

For research, education and patient care in the area of gut-brain interactions

We are pleased to announce a joint award of the Rome Foundation with the Aldo Torsoli Foundation in the area of ​​GI Functional Disorders. Applicants must hold a medical degree or Ph.D. and have an academic record of research, education, and patient care in the area of ​​gut-brain interaction disorders (DGBI, formerly FGID).

Click HERE to submit the application form.
Please note that applications and self-applications both require a letter of recommendation and completion of the required online forms. To be considered for this award, the candidate must be a middle or senior level and have an academic record of research, education, and patient care in the area of ​​intestinal brain interactions (DGBI). Applicants must have completed an MD or PhD and be currently active in DGBI research.

The recipient of the award will be selected by a joint Scientific Selection Committee composed of six members, three from each Foundation. The award will be presented during the Fondazione di Roma’s annual reception at DDW in May 2022. After the DDW, the recipient will hold a lecture on their work which will eventually be available for online streaming.

2024 Aldo Torsoli Award

Maura Corsetti, MD PhD
Maura Corsetti graduated in Medicine and obtained her Specialisation (2000) and PhD (2004) at the University of Milan, Italy.
During her PhD, she worked for two years (2001- 2002) as a research fellow at the Gastrointestinal Motility and Sensitivity Research Group of the Translational Research Centre for Gastrointestinal Disorders (TARGID) at the University of Leuven, Belgium, acquiring expertise in the study of gastrointestinal motility and sensitivity in functional bowel disorders.
For eight years (2004-2012), she was a clinical reference consultant for functional gastrointestinal (GI) disorders at the San Raffaele University Hospital in Milan. This was a clinical assignment with no specific time frame for research.

For this reason, she decided to return to TARGID in 2012 where she worked for four years as Senior Research Supervisor in charge of the development of high-resolution colonic manometry. She is one of two world experts in this technique.

In April 2016 Maura was appointed Associate Professor of Gastroenterology at the University of Nottingham where she leads the Functional Gastroenterology Clinic, the Gastrointestinal Motility Unit and has 5 PAs dedicated to academic work.

Maura is an internationally recognised expert in functional gastrointestinal disorders and, in particular, the study of gastrointestinal motility, as evidenced by her role as Editor-in-Chief of Neurogastroenterology and Motility, the official journal of the European (ESNM) and American Society of Neurogastroenterology and Motility, as secretary of the British Society of Gastroenterology (BSG) Neurogastroenterology and Motility Committee and as a member of the BSG Food and Function Committees, as ESNM representative to the United European Gastroenterology Scientific Committee, as co-chair of the UEG postgraduate course and co- chair of the Bowel Disorders Committee of the Roma V Foundation.

2023 Aldo Torsoli Award

Ronnie Fass, MD MACG

Ronnie Fass, MD MACG, is the Medical Director of the Digestive Health Center, Chairman of the Division of Gastroenterology and Hepatology, and head of the Esophageal and Swallowing Program at the MetroHealth Medical Center, Cleveland Ohio. He is also a tenured professor of medicine at Case Western Reserve University. Dr. Fass did his internship and residency in internal medicine at the University of Arizona Health Sciences Center, where he later became a Chief Resident. He then completed a fellowship in gastroenterology at the University of California in Los Angeles where he focused on GI motility and disorders of gut-brain interaction.

Dr. Fass has served in leadership positions in many societies. He is the former treasurer of the American Neurogastroenterology and Motility Society as well as the chair of the education committee. The former member of the Nominating Committees of the Upper GI Section and Neurogastroenterology and Motility of the American Gastroenterological Association (AGA). He has served as the chair of the Functional Esophageal Disorders committee for Rome IV, Membership committee of the American Neurogastroenterology and Motility Society, Practice Parameter Committee and Audio Committee of the American College of Gastroenterology (ACG) and the Publication Committee of the American Society of Gastrointestinal Endoscopy (ASGE). He has also served as a member of the management committee of the journal Neurogastroenterology and Motility. Moreover, Dr. Fass has served as a member of many committees in different GI societies. Currently Dr. Fass serves as a member of the World Gastroenterology Organization (WGO) Guidelines and Publications committee, member of the ACG Digital communications and publications committee, member of The American Foregut Society (AFS) research committee, member of the International Society of Diseases of the esophagus (ISDE), education committee and the ACG GI on demand task force steering committee. In addition, Dr. Fass has served on the ANMS/EMS consensus group for Refractory GERD and as a core team member of Chicago Classification 4.0. He is currently a member of the EndoFlip experts panel working group, Rome V for functional esophageal disorders, Lyon 2.0 for GERD metrics (core member) and the multi-society guidelines for endoscopy credentialing (Representative of the AFS). Currently, he is leading the AFS consensus for Nonerosive reflux disease (NERD) and the World Gastroenterological Organization (WGO) GERD guidelines committee.

Dr. Fass is the editor-in-chief of the Journal of Clinical Gastroenterology and he is the editor-in-chief of the Journal of Neurogastroenterology and Motility. Dr. Fass is a frequent lecturer and presenter and is a reviewer for more than 70 journals. He is and has served on the editorial board of 27 journals.

Dr. Fass is the recipient of the American Gastroenterological Association Award for Digestive Sciences in Clinical Research, the Southern Arizona VA Health Care System Investigator of the Year Award, and the International Foundation of Functional Gastrointestinal Disorders Senior Clinical Investigator Award. He has received the University of Arizona Dean’s Research Award, the Glaxo Institute of Digestive Health Clinical Research Award twice, the American College of Gastroenterology Research Award three times, the American Medical Association Resident-Mentor Award twice, and the American Journal of Gastroenterology Outstanding Reviewer Award. Dr. Fass has been selected as one of the Best Doctors in Arizona between 2004 and 2011, Best Doctor in Northern Ohio between 2012 and 2016, Castle Connolly Top Doctor from 2015-2023 and America’s Top Doctor in 2021-2023. Dr. Fass was named World’s Leading Expert in the research and treatment of GERD (press release 11/2013) and World’s expert in esophageal motility disorders (Press release 7/2019) by Expertscape.com. He is one of the 5 recipients of Mastership in Gastroenterology (MACG) for 2021 by the American College of Gastroenterology. Dr. Fass is the recipient of the 2023 Aldo Torsoli Award of the Rome Foundation for excellence in research, education and patient care in the area of disorders of gut-brain interactions (DGBIs). He is also the recipient of the 2023 Ray Clouse Visiting Professors of Excellence by Washington University in Saint Louis. Dr. Fass has delivered numerous named lectureships and key note presentations. In 2023 he delivered the ACG lectureship during the Japanese GI Society annual meeting and was a Keynote speaker at Stanford University annual GI meeting.

Dr. Fass research has focused on DGBI, specifically esophageal disorders, such as functional esophageal disorders, GERD, BE, dysphagia, esophageal dysmotility and others. He has received research grants from societies, academic and federal institutions as well as drug and device companies.
Dr. Fass has published more than 450 articles, editorials, and commentaries in journals such as New England Journal of Medicine, Gastroenterology, Gut, American Family Physician, American Journal of Gastroenterology, Archives of Internal Medicine, Lancet Gastroenterology and Hepatology and Nature reviews Primer. He has published three books and has written 62 book chapters, including 2 chapters in UpToDate.

2022 Aldo Torsoli Award

Hans Törnblom, MD PhD

Associate Professor of Gastroenterology and Senior Consultant Gastroenterologist
Dept of Molecular and Clinical Medicine, Inst of Internal Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Dr Törnblom is a clinical scientist and educator in the field of disorders of gut-brain interaction (DGBI). As a physician, the management of patients with severe, incapacitating GI symptoms not responding to standard therapies is central. His research has a focus on pathophysiologic mechanisms and intervention studies in irritable bowel syndrome, functional dyspepsia, and severe gastrointestinal neuromuscular disease. He is current co-chair in the Rome V committee for Gastroduodenal Disorders and was member of the Rome Foundation Working Team report on Neuromodulators for FGIDs.

2021 Aldo Torsoli Award

Carlo Di Lorenzo, MD

Carlo Di Lorenzo, MD, is Chief of the Division of Pediatric Gastroenterology, Hepatology and Nutrition at Nationwide Children’s Hospital where he holds the Robert F. and Edgar T. Wolfe Foundation Endowed Chair in Pediatric Gastroenterology and Professor of Clinical Pediatrics at The Ohio State University College of Medicine. Named multiple times among the “Best Doctors in America,” Dr. Di Lorenzo has served on the editorial board of the Journal of Pediatric Gastroenterology, Hepatology and Nutrition and the Journal of Neurogastroenterology and Motility. He has functioned as a grant reviewer for the National Institutes of Health and abstract reviewer for the American Gastroenterological Association (AGA).
2020 Aldo Torsoli Award
Professor Alexander C. Ford, MBChB, MD, FRCP

Dr. Ford is a proponent of evidence-based medicine, with an interest in disorders of brain-gut interaction (DGBI). His work has informed management guidelines in both the UK and USA, and has informed treatment paradigms for several DGBI. He is the principal investigator of the ATLANTIS study in the UK, a large randomised controlled trial of amitriptyline for irritable bowel syndrome.

2019 Aldo Torsoli Award
Roberto de Giorgio MD, PhD
Dr. de Giorgio has made significant contributions to the understanding of the structural and functional organization of the enteric nervous system in normal and disease states with focus on neurodegenerative and inflammatory diseases and enteric neuropathies.